theory clinical_14_6
imports Main

begin

typedecl entity
typedecl event

consts
  BRCA2 :: "entity ⇒ bool"
  RAD51 :: "entity ⇒ bool"
  Repair :: "entity ⇒ bool"
  Humans :: "entity ⇒ bool"
  Involved :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  In :: "event ⇒ entity ⇒ bool"
  Molecules :: "entity ⇒ bool"
  Binding :: "event ⇒ bool"
  Joining :: "event ⇒ bool"
  Undamaged :: "entity ⇒ bool"
  Homologous :: "entity ⇒ bool"
  Catalyze :: "event ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Promotion :: "event ⇒ bool"
  HomologousRepair :: "entity ⇒ bool"
  Essential :: "event ⇒ bool"
  For :: "event ⇒ event ⇒ bool"
  Promote :: "event ⇒ bool"
  Through :: "event ⇒ entity ⇒ bool"
  Interaction :: "entity ⇒ bool"
  Process :: "event ⇒ bool"
  Occur :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"

(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair in humans. *)
axiomatization where
  explanation_1: "∃x y z e. BRCA2 x ∧ RAD51 y ∧ Repair z ∧ Humans x ∧ Involved e ∧ Agent e x ∧ Agent e y ∧ In e z"

(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this binding is essential for the promotion of joining undamaged homologous repair molecules. *)
axiomatization where
  explanation_2_1: "∃x y z e1 e2. BRCA2 x ∧ RAD51 y ∧ Molecules z ∧ Binding e1 ∧ Joining e2 ∧ Undamaged z ∧ Homologous z ∧ Catalyze e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Patient e1 z"

axiomatization where
  explanation_2_2: "∃x y z e1 e2. Binding x ∧ Promotion y ∧ Joining z ∧ Undamaged y ∧ HomologousRepair y ∧ Essential e1 ∧ For e1 y ∧ Patient e1 z"

(* Explanation 3: BRCA2, through its interaction with RAD51 homolog 1, promotes the joining of undamaged homologous repair molecules in humans, and this interaction is essential for the promotion process. *)
axiomatization where
  explanation_3_1: "∃x y z e1 e2. BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans x ∧ Joining e2 ∧ Undamaged y ∧ HomologousRepair y ∧ Promote e2 ∧ Agent e1 x ∧ Patient e1 y ∧ Through e1 z ∧ In e1 y"

axiomatization where
  explanation_3_2: "∃x y e. Interaction x ∧ Promotion y ∧ Process e ∧ Essential e ∧ For e y"

(* Explanation 4: The promotion occurs via RAD51 homolog. *)
axiomatization where
  explanation_4: "∃x y e. Promotion x ∧ RAD51 y ∧ Occur e ∧ Via e y"

theorem hypothesis:
  assumes asm: "BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e1"
  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
  shows "∃x y z e1 e2. BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e1 ∧ Joining e2 ∧ Undamaged y ∧ HomologousRepair y ∧ Promote e2 ∧ Agent e1 x ∧ Patient e1 y ∧ Via e1 z ∧ In e1 y"
proof -
  (* From the known information, we have BRCA2 x, Molecules y, RAD51 z, and Humans e1. *)
  from asm have "BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e1" <ATP>
  (* Explanation 3 states that BRCA2, through its interaction with RAD51 homolog 1, promotes the joining of undamaged homologous repair molecules in humans. *)
  (* This is related to logical proposition E. *)
  (* We can use the logical relation Implies(E, G) to infer that promotion occurs via RAD51 homolog. *)
  have "Promotion occurs via RAD51 homolog" <ATP>
  (* From the derived implication Implies(E, G), we know that if BRCA2 interaction with RAD51 homolog 1 promotes the joining of undamaged homologous repair molecules, then promotion occurs via RAD51 homolog. *)
  (* Therefore, we can conclude that BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
  then have "∃x y z e1 e2. BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e1 ∧ Joining e2 ∧ Undamaged y ∧ HomologousRepair y ∧ Promote e2 ∧ Agent e1 x ∧ Patient e1 y ∧ Via e1 z ∧ In e1 y" <ATP>
  then show ?thesis <ATP>
qed

end
